A
Adverum Biotechnologies D
D
ADVM
5.39000
USD
0.11
(2.08%)
مغلق
حجم التداول
7,695
الربح لكل سهم
-7
العائد الربحي
-
P/E
-1
حجم السوق
113,104,628
الأخبار المقالات
العنوان: Adverum Biotechnologies
القطاع: Healthcare
الصناعة: Biotechnology
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.